Catalyst Funds Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,800
Closed -$114K 1665
2024
Q2
$114K Buy
+2,800
New +$114K 0.03% 264